S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Lyra Therapeutics (LYRA) News Today

$5.19
-0.20 (-3.71%)
(As of 04/19/2024 ET)
SourceHeadline
finance.yahoo.com logoPrivate equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well
finance.yahoo.com - March 26 at 9:28 PM
marketbeat.com logoLyra Therapeutics (NASDAQ:LYRA) Price Target Cut to $11.00
marketbeat.com - March 25 at 8:10 AM
finance.yahoo.com logoLyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections
finance.yahoo.com - March 23 at 5:46 AM
markets.businessinsider.com logoOptimistic Buy Rating for Lyra Therapeutics’ LYR-210 Amidst Phase 3 Trial and Market Opportunity
markets.businessinsider.com - March 22 at 7:46 PM
msn.com logoLyra Therapeutics files for $300M mixed shelf
msn.com - March 22 at 7:46 PM
marketbeat.com logoLyra Therapeutics (NASDAQ:LYRA) Receives "Buy" Rating from HC Wainwright
marketbeat.com - March 22 at 8:17 AM
globenewswire.com logoLyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
globenewswire.com - March 21 at 4:01 PM
marketbeat.com logoLyra Therapeutics, Inc. (NASDAQ:LYRA) Short Interest Down 13.6% in February
marketbeat.com - March 16 at 6:46 PM
finance.yahoo.com logoLYRA Jul 2024 2.500 call
finance.yahoo.com - March 15 at 11:36 PM
finance.yahoo.com logoLYRA Jul 2024 7.500 call
finance.yahoo.com - March 15 at 1:27 PM
finance.yahoo.com logoLYRA Apr 2024 7.500 put
finance.yahoo.com - March 15 at 2:57 AM
finance.yahoo.com logoLYRA May 2024 7.500 call
finance.yahoo.com - March 15 at 2:57 AM
marketbeat.com logoArmistice Capital LLC Cuts Position in Lyra Therapeutics, Inc. (NASDAQ:LYRA)
marketbeat.com - March 3 at 10:50 AM
globenewswire.com logoLyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - March 1 at 4:01 PM
finance.yahoo.com logoHere's What Could Help Lyra Therapeutics, Inc. (LYRA) Maintain Its Recent Price Strength
finance.yahoo.com - February 21 at 4:36 PM
marketbeat.com logoLyra Therapeutics (NASDAQ:LYRA) Trading Down 1%
marketbeat.com - February 14 at 2:25 AM
bizjournals.com logoLyra Therapeutics invests in Mass. manufacturing with new HQ
bizjournals.com - February 12 at 7:51 AM
businessinsider.com logoThese are the 7 healthcare startups primed to IPO when the market reopens
businessinsider.com - January 29 at 7:03 AM
msn.com logo15 Unhappiest States in the US
msn.com - January 28 at 8:13 PM
finance.yahoo.com logoWhat Makes Lyra Therapeutics, Inc. (LYRA) a Good Fit for 'Trend Investing'
finance.yahoo.com - January 17 at 3:59 PM
marketbeat.com logoLyra Therapeutics, Inc. (NASDAQ:LYRA) Sees Significant Decline in Short Interest
marketbeat.com - December 30 at 2:21 PM
benzinga.com logoLyra Therapeutics Stock (NASDAQ:LYRA) Dividends: History, Yield and Dates
benzinga.com - December 27 at 9:04 AM
marketbeat.com logoAnalysts Issue Forecasts for Lyra Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:LYRA)
marketbeat.com - December 21 at 7:46 AM
marketbeat.com logoLyra Therapeutics' (LYRA) Overweight Rating Reiterated at Cantor Fitzgerald
marketbeat.com - December 21 at 7:36 AM
marketbeat.com logoPerceptive Advisors LLC Purchases 3,610,832 Shares of Lyra Therapeutics, Inc. (NASDAQ:LYRA)
marketbeat.com - December 13 at 10:59 AM
finance.yahoo.com logoExecutive Chairman of Lyra Therapeutics Harlan Waksal Buys 11% More Shares
finance.yahoo.com - November 15 at 7:30 AM
finance.yahoo.com logoLyra Therapeutics Insider Ups Holding By 11% During Year
finance.yahoo.com - November 15 at 7:30 AM
benzinga.com logoExecutive Chair of Lyra Therapeutics Purchased $74K In Stock
benzinga.com - November 14 at 4:29 PM
benzinga.com logoSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Lyra Therapeutics, Inc. (NASDAQ: LYRA) and Encourages Investors to Contact the Firm
benzinga.com - November 11 at 9:39 AM
msn.com logoLyra Therapeutics GAAP EPS of -$0.27, revenue of $544M
msn.com - November 7 at 9:03 PM
finance.yahoo.com logoLyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 9:03 PM
benzinga.com logoLyra Therapeutics Announces Appointment of Ronan O'Brien as Chief Legal Officer
benzinga.com - October 16 at 8:25 AM
finance.yahoo.com logoLyra Therapeutics Announces Appointment of Ronan O’Brien as Chief Legal Officer
finance.yahoo.com - October 16 at 8:25 AM
finance.yahoo.com logoLyra Therapeutics, Inc.'s (NASDAQ:LYRA) market cap dropped US$20m last week; Private equity firms bore the brunt
finance.yahoo.com - October 11 at 7:30 AM
msn.com logoLyra Therapeutics: Hold For Phase 3 Topline
msn.com - October 10 at 4:06 PM
msn.com logoLyra Therapeutics' Nasal Matrix In Focus: Sniffing Out Opportunity
msn.com - October 9 at 9:01 AM
markets.businessinsider.com logoWhat 4 Analyst Ratings Have To Say About Lyra Therapeutics
markets.businessinsider.com - October 6 at 1:37 PM
msn.com logoHC Wainwright & Co. Reiterates Lyra Therapeutics (LYRA) Buy Recommendation
msn.com - October 3 at 8:23 AM
marketbeat.com logoWilliam Blair Analysts Raise Earnings Estimates for Lyra Therapeutics, Inc. (NASDAQ:LYRA)
marketbeat.com - September 15 at 7:33 AM
finance.yahoo.com logoLyra (LYRA) Posts Upbeat Data on Rhinosinusitis Study, Stock Up
finance.yahoo.com - September 13 at 7:15 PM
nasdaq.com logoB of A Securities Maintains Lyra Therapeutics (LYRA) Buy Recommendation
nasdaq.com - September 12 at 9:01 PM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Lyra Therapeutics (LYRA)
markets.businessinsider.com - September 12 at 4:00 PM
marketwatch.com logoLyra Therapeutics Phase 2 Chronic Rhinosinusitis Study Hits Main Endpoint >LYRA
marketwatch.com - September 12 at 10:10 AM
marketwatch.com logoLyra Therapeutics Shares Rise Premarket on Phase 2 Study Success
marketwatch.com - September 12 at 10:10 AM
markets.businessinsider.com logoLyra Therapeutics Reports Positive Topline Results From BEACON Phase 2 Study Of LYR-220
markets.businessinsider.com - September 12 at 10:10 AM
finance.yahoo.com logoLyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus Surgery
finance.yahoo.com - September 12 at 10:10 AM
marketbeat.com logo
marketbeat.com - September 12 at 6:56 AM
finance.yahoo.com logoLyra Therapeutics to Participate in Upcoming Investor Conferences
finance.yahoo.com - September 6 at 7:12 PM
marketbeat.com logoEquities Analysts Set Expectations for Lyra Therapeutics, Inc.'s Q3 2023 Earnings (NASDAQ:LYRA)
marketbeat.com - September 4 at 1:27 AM
finance.yahoo.com logoIs Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - August 31 at 8:02 PM
Get Lyra Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LYRA and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

LYRA Media Mentions By Week

LYRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LYRA
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

LYRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LYRA Articles
This Week

0

1

LYRA Articles
Average Week

Get Lyra Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LYRA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LYRA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners